国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

000028 国药一致

已收盘 12-12 15:00:00

{"stockData":{"symbol":"000028","market":"SZ","secType":"STK","nameCN":"国药一致","latestPrice":24.69,"timestamp":1765523022000,"preClose":24.94,"halted":0,"volume":5002295,"delay":0,"changeRate":-0.01,"floatShares":478000000,"shares":557000000,"eps":0.9596,"marketStatus":"已收盘","change":-0.25,"latestTime":"12-12 15:00:00","open":24.94,"high":24.98,"low":24.52,"amount":124000000,"amplitude":0.0184,"askPrice":24.69,"askSize":22,"bidPrice":24.67,"bidSize":13,"shortable":0,"etf":0,"ttmEps":0.9596,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":24.94,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":27.43,"lowLimit":22.45,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":556565077,"isCdr":false,"pbRate":0.75,"roa":"--","peRate":25.729471,"roe":"5.29%","epsLYR":1.15,"committee":0.574194,"marketValue":13742000000,"turnoverRate":0.0105,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-12-15。","floatMarketCap":11803000000},"requestUrl":"/m/hq/s/000028/tweets","defaultTab":"tweets","newsList":[{"id":"2590502516","title":"国药一致（000028）披露拟清算注销三家子公司，12月12日股价下跌1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590502516","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590502516?lang=zh_cn&edition=full","pubTime":"2025-12-12 22:27","pubTimestamp":1765549623,"startTime":"0","endTime":"0","summary":"截至2025年12月12日收盘，国药一致报收于24.69元，较前一交易日下跌1.0%，最新总市值为137.42亿元。该股当日开盘24.94元，最高24.98元，最低24.52元，成交额达1.24亿元，换手率为1.05%。根据近日发布的第十届董事会2025年第八次临时会议决议公告，国药集团一致药业股份有限公司于2025年12月11日以通讯表决方式召开会议，审议通过多项议案。公告指出，上述清算注销事项不会对公司的整体业务经营产生重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200041868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0175","BK0196","000028","BK0082","BK0028","BK0250","BK0188","BK0010"],"gpt_icon":0},{"id":"2590230435","title":"国药一致：披露估值提升计划增进市场认同","url":"https://stock-news.laohu8.com/highlight/detail?id=2590230435","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590230435?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:00","pubTimestamp":1765353623,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致12月10日在投资者关系平台上答复投资者关心的问题。请问公司管理层是否关注公司的投资价值，是否认可公司B股股价真实反映了公司质量？公司于11月29日披露了估值提升计划，将围绕稳经营、提质效，做强医药分销及零售主业，提高分红比率，加强与投资者交流，持续提升信息披露质量等方式增进市场认同，努力推动公司价值合理反映上市公司质量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000020201.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0185","BK0250","BK0028","BK0175","BK0196","BK0082","BK0188","000028"],"gpt_icon":0},{"id":"2586347733","title":"国药一致（000028）披露估值提升计划，11月28日股价下跌0.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586347733","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586347733?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:29","pubTimestamp":1764340193,"startTime":"0","endTime":"0","summary":"截至2025年11月28日收盘，国药一致报收于24.88元，较前一交易日下跌0.4%，最新总市值为138.47亿元。该股当日开盘25.02元，最高25.05元，最低24.83元，成交额达6124.9万元，换手率为0.51%。近日，国药集团一致药业股份有限公司发布公告称，因股票连续12个月每个交易日收盘价低于最近一个会计年度经审计的每股净资产，公司已触发估值提升计划制定条件。董事会认为该计划有助于提升公司投资价值和增强投资者回报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800040592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0082","BK0196","BK0250","BK0188","BK0185","000028","BK0010","BK0175","BK0028"],"gpt_icon":0},{"id":"2586243335","title":"国药一致：国大药房前三季度净利润同比大幅增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2586243335","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586243335?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:45","pubTimestamp":1764233111,"startTime":"0","endTime":"0","summary":"影响药房盈利的核心因素有很多，包括市场环境变化、品类聚焦效果、门店单店产出能力及成本控制水平等等，公司已通过战略性闭店、商品结构优化、统采体系升级等措施提升毛利率，国大药房前三季度净利润同比有较大幅度增长，展现提质增效成果。B股问题的解决需全面统筹考虑，不只取决于个别指标。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700022827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"gpt_icon":0},{"id":"2586248600","title":"国药一致：SPD业务处于成长期竞争激烈","url":"https://stock-news.laohu8.com/highlight/detail?id=2586248600","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586248600?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:30","pubTimestamp":1764232253,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致11月27日在投资者关系平台上答复投资者关心的问题。预计带来多少收益？SPD项目由医疗机构招投标确定，目前SPD业务在国内还处于成长期，在医疗机构的渗透处于提升阶段，竞争激烈，以收取服务费为主，公司作为医药分销企业仍为相关医疗机构提供配送服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700021298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0175","BK0082","BK0188","BK0250","BK0010","BK0196","000028","BK0028"],"gpt_icon":0},{"id":"2582806484","title":"股市必读：国药一致（000028）11月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2582806484","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582806484?lang=zh_cn&edition=full","pubTime":"2025-11-11 01:22","pubTimestamp":1762795341,"startTime":"0","endTime":"0","summary":"截至2025年11月10日收盘，国药一致报收于25.79元，上涨0.98%，换手率0.87%，成交量4.14万手，成交额1.06亿元。董秘最新回复投资者： 董秘，你好！国药一致器械业务的发展，还会不会继续去拿下更多的SPD业务？后续将持续深化SPD业务布局。交易信息汇总资金流向11月10日主力资金净流出1261.22万元；游资资金净流出220.58万元；散户资金净流入1481.8万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100000559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0188","BK0010","000028","BK0185","BK0175","BK0028","BK0196","BK0082"],"gpt_icon":0},{"id":"2582982374","title":"国药一致：SPD业务持续深化发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2582982374","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582982374?lang=zh_cn&edition=full","pubTime":"2025-11-10 16:27","pubTimestamp":1762763230,"startTime":"0","endTime":"0","summary":"最近这五年，医院供应链延伸项目的医用耗材配送服务项目发展如火如荼，国药一致在广州深圳两地中标运营的项目有什么变化？国药一致器械业务的发展，还会不会继续去拿下更多的SPD业务？公司在SPD业务领域持续深化发展，通过强化中台服务能力和项目统筹管理，供应链增值服务项目数量在两广区域处于领先地位，有效构建标准化、高效率、可复制的服务能力。后续将持续深化SPD业务布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000020567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028","BK0188","BK0028","BK0010","BK0185","BK0250","BK0175","BK0082","BK0196"],"gpt_icon":0},{"id":"2580245848","title":"股市必读：国药一致（000028）11月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2580245848","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580245848?lang=zh_cn&edition=full","pubTime":"2025-11-04 01:13","pubTimestamp":1762189994,"startTime":"0","endTime":"0","summary":"截至2025年11月3日收盘，国药一致报收于25.39元，下跌0.12%，换手率0.69%，成交量3.32万手，成交额8422.64万元。董秘最新回复投资者： 请问贵公司股票长期破净，是否有股票回购计划？当日关注点来自交易信息汇总：11月3日主力资金净流入2079.07万元，占总成交额24.68%，呈现显著主力吸筹迹象。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400000898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0196","BK0185","BK0188","BK0028","BK0250","BK0082","BK0010","000028"],"gpt_icon":0},{"id":"2580264831","title":"国药一致：制定市值管理制度提升信","url":"https://stock-news.laohu8.com/highlight/detail?id=2580264831","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580264831?lang=zh_cn&edition=full","pubTime":"2025-11-03 15:54","pubTimestamp":1762156449,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致(000028)11月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司股票长期破净，是否有股票回购计划？亦或是有无其他提振股东信心的措施？国药一致回复：感谢您的关注！公司围绕稳经营、提质效，做强医药分销及零售主业，提高分红比率，加强与投资者交流，持续提升信息披露质量等方式增进市场认同，并制定了市值管理制度，努力推动公司价值合理反映上市公司质量。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300017552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0250","BK0196","BK0010","BK0028","BK0188","BK0175","000028","BK0082"],"gpt_icon":0},{"id":"2580126100","title":"国药一致：结合政策导向服务中老年群体","url":"https://stock-news.laohu8.com/highlight/detail?id=2580126100","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580126100?lang=zh_cn&edition=full","pubTime":"2025-11-03 15:54","pubTimestamp":1762156447,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致11月03日在投资者关系平台上答复投资者关心的问题。公司以医药分销及零售为主责主业，其中零售药店是重要的服务提供场景，结合国家的政策导向，为广大中老年群体提供多元化服务；随着市场的变化，我们加大对创新药品，医疗器械类、大健康保健类产品的重视，与国内外厂家合作，将更多更好的产品提供给医疗机构和患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300017542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0082","BK0188","000028","BK0185","BK0250","BK0010","BK0196","BK0175"],"gpt_icon":0},{"id":"2580059614","title":"每周股票复盘：国药一致（000028）Q3净利降9.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580059614","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580059614?lang=zh_cn&edition=full","pubTime":"2025-11-02 10:26","pubTimestamp":1762050371,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，国药一致报收于25.42元，较上周的25.44元下跌0.08%。本周，国药一致10月27日盘中最高价报25.58元。10月31日盘中最低价报25.28元。国药一致当前最新总市值141.48亿元，在医药商业板块市值排名7/32，在两市A股市值排名1353/5163。其中2025年第三季度，公司单季度主营收入183.28亿元，同比下降1.89%；单季度归母净利润2.91亿元，同比下降9.58%；单季度扣非净利润2.8亿元，同比下降10.42%。负债率57.38%，投资收益1.65亿元，财务费用1.2亿元，毛利率10.49%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200002391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0082","BK0175","BK0010","000028","BK0188","BK0250","BK0185","BK0196"],"gpt_icon":0},{"id":"2579140920","title":"图解国药一致三季报：第三季度单季净利润同比下降9.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579140920","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579140920?lang=zh_cn&edition=full","pubTime":"2025-10-30 21:32","pubTimestamp":1761831164,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致2025年三季报显示，前三季度公司主营收入551.24亿元，同比下降2.38%；归母净利润9.57亿元，同比下降10.18%；扣非净利润9.23亿元，同比下降9.87%；其中2025年第三季度，公司单季度主营收入183.28亿元，同比下降1.89%；单季度归母净利润2.91亿元，同比下降9.58%；单季度扣非净利润2.8亿元，同比下降10.42%；负债率57.38%，投资收益1.65亿元，财务费用1.2亿元，毛利率10.49%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000043464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"gpt_icon":0},{"id":"1127818032","title":"国药一致第三季度净利润同比下降9.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1127818032","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127818032?lang=zh_cn&edition=full","pubTime":"2025-10-30 18:19","pubTimestamp":1761819587,"startTime":"0","endTime":"0","summary":"10月30日——国药一致（中国国药控股有限公司）第三季度净利润同比下降9.6%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK0175","01099","BK0188","LU0640798160.USD","BK0250","BK0082","000028","BK0028","BK0196","BK1500","BK0010","BK1197","BK0185","LU1115378108.SGD"],"gpt_icon":0},{"id":"2578507876","title":"每周股票复盘：国药一致（000028）前三季度净利降10.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578507876","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578507876?lang=zh_cn&edition=full","pubTime":"2025-10-26 03:34","pubTimestamp":1761420852,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，国药一致报收于25.44元，较上周的25.16元上涨1.11%。本周，国药一致10月23日盘中最高价报25.74元。本周关注点业绩披露要点：国药一致前三季度归属净利润9.57亿元，同比下降10.18%。公司公告汇总国药一致发布2025年度前三季度业绩快报。2025年第三季度，营业总收入183.28亿元，同比下降1.89%；归属于上市公司股东的净利润2.91亿元，同比下降9.58%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600000785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0028","BK0196","000028","BK0082","BK0250","BK0175","BK0188","BK0010"],"gpt_icon":0},{"id":"2577467328","title":"大摩：相信国药控股未来30天内股价将升 目标价22.5港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577467328","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577467328?lang=zh_cn&edition=full","pubTime":"2025-10-23 11:19","pubTimestamp":1761189540,"startTime":"0","endTime":"0","summary":"大摩发布研报称，相信国药控股(01099)未来30天内股价将升，发生机率70%至80%，评级“增持”，目标价22.5港元。大摩指，受国内需求疲软及中国技术授权活动影响，药品分销商在2025年持续未受 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20251023/c671949699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0196","BK0185","BK0082","BK0175","000028","BK0012","BK0097","BK0250","BK0028","BK0188","BK0010","600511"],"gpt_icon":0},{"id":"2577828713","title":"国药一致（000028）披露2025年度前三季度业绩快报，10月21日股价上涨0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577828713","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577828713?lang=zh_cn&edition=full","pubTime":"2025-10-21 17:23","pubTimestamp":1761038602,"startTime":"0","endTime":"0","summary":"截至2025年10月21日收盘，国药一致报收于25.34元，较前一交易日上涨0.2%，最新总市值为141.03亿元。该股当日开盘25.32元，最高25.41元，最低25.3元，成交额达5052.26万元，换手率为0.42%。近日，国药一致发布2025年度前三季度业绩快报。2025年第三季度，营业总收入183.28亿元，同比下降1.89%；归属于上市公司股东的净利润2.91亿元，同比下降9.58%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102100026768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0082","BK0250","BK0185","BK0010","BK0188","BK0028","BK0175","000028"],"gpt_icon":0},{"id":"2577426718","title":"国药一致(000028.SZ)前三季度归母净利润9.57亿元，同比下降10.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577426718","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577426718?lang=zh_cn&edition=full","pubTime":"2025-10-21 16:17","pubTimestamp":1761034668,"startTime":"0","endTime":"0","summary":"智通财经APP讯，国药一致 披露2025年度前三季度业绩快报，公司实现营业收入551.24亿元，同比下降2.38%;归属于上市公司股东的净利润9.57亿元，同比下降10.18%，相应的基本每股收益同比下降9.95%。2025年1-9月，分销板块实现营业收入405.94亿元，同比下降0.59%;实现净利润7.23亿元，同比下降7.32%。零售板块实现营业收入152.26亿元，同比下降7.14%;实现净利润0.13亿元，同比增长133.91%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"国药一致(000028.SZ)前三季度归母净利润9.57亿元，同比下降10.18%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000028"],"gpt_icon":0},{"id":"2570010567","title":"股市必读：国药一致（000028）9月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2570010567","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570010567?lang=zh_cn&edition=full","pubTime":"2025-09-26 01:02","pubTimestamp":1758819744,"startTime":"0","endTime":"0","summary":"截至2025年9月25日收盘，国药一致报收于25.16元，下跌0.79%，换手率0.65%，成交量3.1万手，成交额7807.93万元。董秘最新回复投资者： 董秘你好:公司麻精业务表现怎么样？公司下半年业绩估计会增长多少？公司正在加快推进两广地区麻精业务，鼓励区域公司获取相关资质，整合集团体系内相关资源，尽管目前规模占比不大，增速相对较快。当日关注点来自交易信息汇总：9月25日主力资金净流出409.57万元，占总成交额5.25%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092600000484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028","BK0188","BK0028","BK0010","BK0185","BK0250","BK0175","BK0082","BK0196"],"gpt_icon":0},{"id":"2570069032","title":"国药一致：加快推进两广地区麻精业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2570069032","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570069032?lang=zh_cn&edition=full","pubTime":"2025-09-25 15:45","pubTimestamp":1758786315,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致(000028)09月25日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好:公司麻精业务表现怎么样？公司下半年业绩估计会增长多少？国药一致回复：感谢您的关注！公司正在加快推进两广地区麻精业务，鼓励区域公司获取相关资质，整合集团体系内相关资源，尽管目前规模占比不大，增速相对较快。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092500019421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0082","BK0250","BK0010","BK0196","000028","BK0185","BK0028","BK0175"],"gpt_icon":0},{"id":"2564031166","title":"股市必读：国药一致（000028）9月3日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2564031166","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564031166?lang=zh_cn&edition=full","pubTime":"2025-09-04 04:25","pubTimestamp":1756931113,"startTime":"0","endTime":"0","summary":"截至2025年9月3日收盘，国药一致报收于25.35元，下跌1.52%，换手率0.84%，成交量4.02万手，成交额1.03亿元。机构调研要点公司对分销板块的整体业绩预期与去年基本持平。信用减值损失同比上升主因应收账款账龄延长及规模增加。经营活动现金流同比下降主要受分销回款周期延长及国大药房收入负增长影响。应收账款管理将加强资信审查，实施账期与额度双控，压减高风险业务，清理高风险客户并依法催收，推动回款改善。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090400003082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0250","BK0082","BK0185","BK0196","BK0028","BK0188","BK0010","000028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765682740406,"stockEarnings":[{"period":"1week","weight":-0.0187},{"period":"1month","weight":-0.0482},{"period":"3month","weight":-0.0415},{"period":"6month","weight":-0.0166},{"period":"1year","weight":-0.1864},{"period":"ytd","weight":-0.1433}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"国药集团一致药业股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"0人","perCapita":"--","listingDate":"1993-08-09","address":"广东省深圳市福田区园岭街道八卦四路15号一致药业大厦","registeredCapital":"55656万元","survey":"　　国药集团一致药业股份有限公司的主营业务是医药分销和医药零售。公司的主要产品是药品、器械耗材、诊断试剂、仪器设备。","listedPrice":3.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药一致(000028)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药一致,000028,国药一致股票,国药一致股票老虎,国药一致股票老虎国际,国药一致行情,国药一致股票行情,国药一致股价,国药一致股市,国药一致股票价格,国药一致股票交易,国药一致股票购买,国药一致股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药一致(000028)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}